NKGen Biotech, Inc.
NKGen Biotech, Inc.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease | Moderate Alzheimer Disease | Recruiting | Phase 1 / Phase 2 | 2026-10-02 | NCT06189963 | |
| Open-Label Extension Protocol to SNK01-AD01 Study | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 2 | 2025-11-13 | NCT07228078 |